Abstract:Epithelial-to-mesenchymal transitions (EMTs) are phenotypic plasticity processes that confer migratory and invasive properties to epithelial cells during development, wound-healing, fibrosis and cancer<a href="#ref-CR1">1</a>,<a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>. EMTs are driven by SNAIL, ZEB and TWIST transcription factors<a href="/articles/s41586-019-1897-5#ref-CR5">5</a>,<a href="/articles/s41586-019-1897-5#ref-CR6">6</a> together with microRNAs that balance this regulatory network<a href="/articles/s41586-019-1897-5#ref-CR7">7</a>,<a href="/articles/s41586-019-1897-5#ref-CR8">8</a>. Transforming growth factor β (TGF-β) is a potent inducer of developmental and fibrogenic EMTs<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>,<a href="/articles/s41586-019-1897-5#ref-CR9">9</a>,<a href="/articles/s41586-019-1897-5#ref-CR10">10</a>. Aberrant TGF-β signalling and EMT are implicated in the pathogenesis of renal fibrosis, alcoholic liver disease, non-alcoholic steatohepatitis, pulmonary fibrosis and cancer<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>,<a href="/articles/s41586-019-1897-5#ref-CR11">11</a>. TGF-β depends on RAS and mitogen-activated protein kinase (MAPK) pathway inputs for the induction of EMTs<a href="#ref-CR12">12</a>,<a href="#ref-CR13">13</a>,<a href="#ref-CR14">14</a>,<a href="#ref-CR15">15</a>,<a href="#ref-CR16">16</a>,<a href="#ref-CR17">17</a>,<a href="#ref-CR18">18</a>,<a href="/articles/s41586-019-1897-5#ref-CR19">19</a>. Here we show how these signals coordinately trigger EMTs and integrate them with broader pathophysiological processes. We identify RAS-responsive element binding protein 1 (RREB1), a RAS transcriptional effector<a href="/articles/s41586-019-1897-5#ref-CR20">20</a>,<a href="/articles/s41586-019-1897-5#ref-CR21">21</a>, as a key partner of TGF-β-activated SMAD transcription factors in EMT. MAPK-activated RREB1 recruits TGF-β-activated SMAD factors to SNAIL. Context-dependent chromatin accessibility dictates the ability of RREB1 and SMAD to activate additional genes that determine the nature of the resulting EMT. In carcinoma cells, TGF-β–SMAD and RREB1 directly drive expression of SNAIL and fibrogenic factors stimulating myofibroblasts, promoting intratumoral fibrosis and supporting tumour growth. In mouse epiblast progenitors, Nodal–SMAD and RREB1 combine to induce expression of SNAIL and mesendoderm-differentiation genes that drive gastrulation. Thus, RREB1 provides a molecular link between RAS and TGF-β pathways for coordinated induction of developmental and fibrogenic EMTs. These insights increase our understanding of the regulation of epithelial plasticity and its pathophysiological consequences in development, fibrosis and cancer.

TGF-β downstream of Smad3 and MAPK signaling antagonistically regulate the viability and partial epithelial-mesenchymal transition of liver progenitor cells

Methyl-CpG-binding Domain 3 Inhibits Epithelial–mesenchymal Transition in Pancreatic Cancer Cells Via TGF-β/Smad Signalling

TGF-β1 induced deficiency of linc00261 promotes epithelial–mesenchymal-transition and stemness of hepatocellular carcinoma via modulating SMAD3

Transforming Growth Factor Β Signal Transduction in Hepatic Stellate Cells Via SMAD2/3 Phosphorylation, a Pathway That is Abrogated During in Vitro Progression to Myofibroblasts

Smad Proteins And Hepatocyte Growth Factor Control Parallel Regulatory Pathways That Converge On Beta 1-Integrin To Promote Normal Liver Development

TGF-β1 Induces the Dual Regulation of Hepatic Progenitor Cells with Both Anti- and Proliver Fibrosis

TGF-β Tumor Suppression Through a Lethal EMT

Mechanisms of TGFβ Inhibition of LUNG Endodermal Morphogenesis: the Role of TβRII, Smads, Nkx2.1 and Pten

Loss of YB-1 Alleviates Liver Fibrosis by Suppressing Epithelial-Mesenchymal Transition in Hepatic Progenitor Cells

LncRNA-Smad7 mediates cross-talk between Nodal/TGF-β and BMP signaling to regulate cell fate determination of pluripotent and multipotent cells

A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival

TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis

Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis

Transforming Growth Factor Beta Regulates Hepatic Progenitor Cells Migration Via PI3K/AKT/mTOR/p70S6K Pathway

Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy

Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries

Activated Phosphatidylinositol 3-Kinase/akt Inhibits the Transition of Endothelial Progenitor Cells to Mesenchymal Cells by Regulating the Forkhead Box Subgroup O-3a Signaling

Arginine methylation of SMAD7 by PRMT1 in TGF-β–induced epithelial–mesenchymal transition and epithelial stem-cell generation

<i>LncRNA-Smad7</i> mediates cross-talk between Nodal/TGF-β and BMP signaling to regulate cell fate determination of pluripotent and multipotent cells

TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1

TGF-β Signaling is Often Attenuated During Hepatotumorigenesis, but is Retained for the Malignancy of Hepatocellular Carcinoma Cells.